Navigation Links
Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
Date:1/24/2011

74; (Epoetin alfa) and ENBREL recalls.  These increases were partially offset by lower excess capacity charges and lower royalties, primarily for ENBREL.Research & Development (R&D) expenses decreased 5 percent to $825 million in the fourth quarter of 2010 versus $864 million in the fourth quarter of 2009.  This decrease was driven primarily by the $60 million licensing fee payment in the fourth quarter of 2009 associated with the Array BioPharma agreement.  This decrease in licensing fees was partially offset by lower cost recoveries associated with ongoing collaborations and higher staff related costs in 2010.For the year, R&D expenses were $2,773 million in 2010 versus $2,739 million in 2009, an increase of 1 percent.  The increase was driven primarily by lower cost recoveries associated with ongoing collaborations and higher staff related costs in 2010.  This was largely offset by lower licensing fees, principally associated with payments made in 2009 under the Cytokinetics and Array BioPharma agreements, and reduced denosumab clinical trial expenses in 2010.Selling, General & Administrative (SG&A) expenses declined slightly to $1,142 million in the fourth quarter of 2010 versus $1,159 million in the fourth quarter of 2009.For 2010, SG&A expenses increased 5 percent to $3,925 million versus $3,737 million in 2009.  This increase was due primarily to higher staff related costs, higher promotional costs for Prolia and other marketed products, and higher litigation expenses.ENBREL profit share expenses were $319 million and $1,184 million and $308 million and $1,163 million for the three and twelve months ended Dec. 31, 2010 and 2009, respectively.The adjusted tax rate for the fourth quarter of 2010 was 15.5 percent compared to 15.9 percent for the fourth quarter of 2009.  The decrease was due primarily to the full year benefit of the federal R&D credit recognized in the fourth quarter of
'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
9. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... DUBLIN , Aug. 4, 2015 /PRNewswire/ ... announced the addition of Jain PharmaBiotech,s new ... Markets, and Companies" to their offering. ... transdermal drug delivery - an approach used ... therapeutic use as an alternative to oral,intravascular, ...
(Date:8/4/2015)... York , August 4, 2015 ... titled " Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, ... Others) - Global Industry Analysis, Size, Volume, Share, Growth, ... According to a new market report published by Transparency ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ...
(Date:8/4/2015)... Organovo Holdings, Inc. (NYSE MKT: ONVO; ... scientific and medical breakthroughs using 3D bioprinting technology, ... Paul Gallant as its General Manager of ... Gallant has more than 20 years of management ... most recently serving as chief operating officer for ...
Breaking Medicine Technology:Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3
(Date:8/4/2015)... ... August 04, 2015 , ... NutraScience Labs , a ... services, joined over 200 other Long Island-based corporations as participants in the 10th ... at Jones Beach State Park in Wantagh, New York. , According to Mindy ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... complete with full examination now offered by the world renowned Beverly Hills ... aesthetic facial appearance through cosmetic surgery techniques helps individuals to achieve an outer ...
(Date:8/4/2015)... ... , ... Montclair State University and Atlantic Health System have launched a new ... Jersey, which starting this Fall will help prepare those entering this burgeoning, hybrid field. ... System, one of the largest health care organizations in New Jersey, to design the ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... homes and other long-term care facilities, today announced details of the Advanced level ... homes and centers. , Providigm’s QAPI Accreditation program , introduced in 2013, ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... at unique artistic expressions from a diverse group of exceptionally talented female artists. ... Music & Art Festival on September 25-27, 2015 in Downtown Las Vegas. Curated ...
Breaking Medicine News(10 mins):Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4
... Wound Care,Innovations, LLC, a subsidiary of Wound ... the 510k clearance of a new wound,management product ... new addition to our product line (patent pending) ... (PSGAG) and will initially be available in gel ...
... Cord Blood,America, Inc. (OTC Bulletin Board: CBAI), the ... ) focused on,bringing the life saving potential of ... that a letter to shareholders from CEO Matthew,Schissler ... letter explains,some of the positive scientific and economic ...
... Corgenix Medical Corporation,(OTC Bulletin Board: CONX), a ... sales of $2,001,896 for the first fiscal,quarter ended ... quarter,ended September 30, 2007, a decrease of 4.9%. ... over the same period,in the prior fiscal year., ...
... China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- China,Information Security ... Information,Security," "CIST" or the "Company"), a leading ... Information,Systems ("GIS") solutions provider to public security ... for 2009., China Information Technology has ...
... people choose to get representation when they apply for SSDI, a ... ... Belleville, IL (Vocus) November 13, 2008 -– Difficult decisions ... and one of the most important is how to begin the ...
... Nov. 13 TheraQuest Biosciences, Inc. a,development ... the U.S.,Food and Drug Administration (FDA) has ... TQ-1015, its abuse deterrent extended release,strong opioid. ... abuse deterrent technology., Najib Babul, PharmD, ...
Cached Medicine News:Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 2Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 3Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 3Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 2Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 4Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 2Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 3Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 4Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 6Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2
... the latest technology and innovative software with ... transmission and auto detection of progressive lenses. ... network with the VELO 8500 Motorized Refractor ... the future. , ,*VELOtm Aculens 186UV can ...
...
...
...
Medicine Products: